Company profile for Next&Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

NextNBio possesses the original technology related to standardized organoid culture, and has the technology to stably mass-produce standardized organoids of the same quality. NextNBio aims to improve the development probability of new drugs , shorten drug approval time , and create cost reduction effects by introducing organoid- based precision patient mimics into the clinical stage based on technological prowess. We are plann...
NextNBio possesses the original technology related to standardized organoid culture, and has the technology to stably mass-produce standardized organoids of the same quality. NextNBio aims to improve the development probability of new drugs , shorten drug approval time , and create cost reduction effects by introducing organoid- based precision patient mimics into the clinical stage based on technological prowess. We are planning to solve the unmet needs of patients who do not have appropriate treatment through customized drug efficacy diagnosis service through precise patient mimetic.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
Seoul National University, Building 105-2, 4F, 433B, 1 Gwanak-ro, Gwanak-gu, S...
Telephone
Telephone
+82(0)2. 6953. 1129
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/19/3208497/0/en/Amplia-Enters-into-Second-Agreement-with-Korean-Specialist-Drug-Screening-Company-Next-Bio-to-Explore-Combination-Therapy-with-FAK-Inhibitor-and-kRAS-Inhibitors.html

GLOBENEWSWIRE
19 Dec 2025

https://www.businesswire.com/news/home/20230516005579/en

BUSINESSWIRE
16 May 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty